USMLE Step 2 CK practice question: Initial nonsevere Clostridioides difficile infection: fidaxomicin as preferred therapy
USMLE Step 2 CKGastrointestinalInternal Medicine
Which of the following is the most appropriate pharmacotherapy?
- Oral fidaxomicin 200 mg twice daily for 10 days
- Oral metronidazole 500 mg three times daily for 14 days
- IV vancomycin 1 g every 12 hours for 10 days
- Fecal microbiota transplantation by colonoscopy
- Oral rifaximin 550 mg three times daily for 14 days
Show answer and explanation
Correct answer: A. Oral fidaxomicin 200 mg twice daily for 10 days
Three or more unformed stools in 24 hours after antibiotic exposure, with a positive toxin assay, confirm Clostridioides difficile infection (CDI). Severity is graded by the leukocyte count and creatinine: nonsevere CDI has a leukocyte count of 15,000/mm³ or less and a creatinine below 1.5 mg/dL; severe CDI exceeds either threshold; fulminant CDI adds hypotension, shock, ileus, or megacolon. This is an initial, nonsevere episode.
The 2021 IDSA/SHEA focused update recommends fidaxomicin 200 mg twice daily for 10 days as preferred therapy for an initial episode, with oral vancomycin 125 mg four times daily for 10 days as an acceptable alternative. Fidaxomicin is a narrow-spectrum macrocyclic antibiotic that spares much of the normal colonic flora, so it achieves similar cure rates but fewer recurrences than vancomycin. Oral metronidazole is reserved for nonsevere disease when neither drug is available. Fulminant disease is treated with high-dose oral (and, with ileus, rectal) vancomycin plus IV metronidazole. The inciting antibiotic should be stopped whenever possible, and antiperistaltic agents are avoided early in treatment.
Why the other options are wrong
- B. Oral metronidazole 500 mg three times daily for 14 days — Metronidazole is less effective and is used only for nonsevere CDI when fidaxomicin and oral vancomycin are unavailable.
- C. IV vancomycin 1 g every 12 hours for 10 days — IV vancomycin is not excreted into the colonic lumen and is ineffective for CDI; vancomycin must be given orally or rectally.
- D. Fecal microbiota transplantation by colonoscopy — Fecal microbiota-based therapy is reserved for multiple recurrences, not a first episode.
- E. Oral rifaximin 550 mg three times daily for 14 days — Rifaximin has been used as a follow-on agent after treatment of recurrent CDI; it is not first-line for an initial episode.
Key point
For an initial episode of C. difficile infection, fidaxomicin is preferred, with oral vancomycin as an alternative; IV vancomycin is ineffective.
Memory hook
Fidaxomicin: fewer flora casualties, fewer comebacks. Vancomycin for C. difficile goes in by mouth; IV never reaches the colon.
15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.
Play free